Drug Discovery Services Market Size, Share, Growth & Industry Analysis, By Therapeutic Area (Neurology, Oncology, Digestive System Diseases, Cardiovascular & Respiratory Diseases and Other Therapeutic Area), By Process, By End-User, By Type, By Drug Type, and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL DRUG DISCOVERY SERVICES MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL DRUG DISCOVERY SERVICES MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTICS AREA
6.1 Overview
6.2 Neurology
6.3 Oncology
6.4 Digestive System Diseases
6.5 Cardiovascular & Respiratory Diseases
6.6 Infectious & Immune System Diseases
6.7 Other Therapeutic Area

7 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY PROCESS
7.1 Overview
7.2 Target Selection
7.3 Target Validation
7.4 Hit-to-lead Identification
7.5 Lead Optimization
7.6 Candidate Validation

8 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END-USER
8.1 Overview
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic Institutes
8.4 Others

9 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPE
9.1 Overview
9.2 Chemistry Services
9.3 Biology Services

10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE
10.1 Overview
10.2 Small-Molecule Drug
10.3 Biologics

11 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY GEOGRAPHY
11.1 Overview

12 NORTH AMERICA 
12.1 U.S.
12.2 Canada
12.3 Mexico

13 EUROPE 
13.1 Germany
13.2 U.K.
13.3 France
13.4 Italy
13.5 Spain
13.6 Russia
13.7 Rest of Europe

14 ASIA-PACIFIC 
14.1 China
14.2 Japan
14.3 India
14.4 South Korea
14.5 Rest of Asia-Pacific

15 MIDDLE EAST & AFRICA 
15.1 GCC
15.2 South Africa
15.3 North Africa
15.4 Rest of Middle East & Africa

16 LATIN AMERICA 
16.1 Brazil
16.2 Argentina
16.3 Rest of South America

17 GLOBAL DRUG DISCOVERY SERVICES MARKET COMPETITIVE LANDSCAPE
17.1 Overview
17.2 Key Developments
17.3 Key Strategic Developments
17.4 Company Market Ranking
17.5 Regional Footprint
17.6 Industry Footprint

18 COMPANY PROFILES
18.1 Labcorp Drug Development
18.1.1 Key Facts
18.1.2 Financial Overview
18.1.3 Product Benchmarking
18.1.4 Recent Developments
18.1.5 Winning Imperatives
18.1.6 Current Focus & Strategies
18.1.7 Threat from competition
18.1.8 SWOT Analysis
18.2 Charles River Laboratories International 
18.2.1 Key Facts
18.2.2 Financial Overview
18.2.3 Product Benchmarking
18.2.4 Recent Developments
18.2.5 Winning Imperatives
18.2.6 Current Focus & Strategies
18.2.7 Threat from competition
18.2.8 SWOT Analysis
18.3 GenScript
18.3.1 Key Facts
18.3.2 Financial Overview
18.3.3 Product Benchmarking
18.3.4 Recent Developments
18.3.5 Winning Imperatives
18.3.6 Current Focus & Strategies
18.3.7 Threat from competition
18.3.8 SWOT Analysis
18.4 Thermo Fisher Scientific Inc.
18.4.1 Key Facts
18.4.2 Financial Overview
18.4.3 Product Benchmarking
18.4.4 Recent Developments
18.4.5 Winning Imperatives
18.4.6 Current Focus & Strategies
18.4.7 Threat from competition
18.4.8 SWOT Analysis
18.5 Pharmaron
18.5.1 Key Facts
18.5.2 Financial Overview
18.5.3 Product Benchmarking
18.5.4 Recent Developments
18.5.5 Winning Imperatives
18.5.6 Current Focus & Strategies
18.5.7 Threat from competition
18.5.8 SWOT Analysis
18.6 Evotec SE
18.6.1 Key Facts
18.6.2 Financial Overview
18.6.3 Product Benchmarking
18.6.4 Recent Developments
18.6.5 Winning Imperatives
18.6.6 Current Focus & Strategies
18.6.7 Threat from competition
18.6.8 SWOT Analysis
18.7 Eurofins Scientific
18.7.1 Key Facts
18.7.2 Financial Overview
18.7.3 Product Benchmarking
18.7.4 Recent Developments
18.7.5 Winning Imperatives
18.7.6 Current Focus & Strategies
18.7.7 Threat from competition
18.7.8 SWOT Analysis
18.8  Piramal Pharma Solutions
18.8.1 Key Facts
18.8.2 Financial Overview
18.8.3 Product Benchmarking
18.8.4 Recent Developments
18.8.5 Winning Imperatives
18.8.6 Current Focus & Strategies
18.8.7 Threat from competition
18.8.8 SWOT Analysis
18.9 Syngene International Limited
18.9.1 Key Facts
18.9.2 Financial Overview
18.9.3 Product Benchmarking
18.9.4 Recent Developments
18.9.5 Winning Imperatives
18.9.6 Current Focus & Strategies
18.9.7 Threat from competition
18.9.8 SWOT Analysis
18.10 Curia Global, Inc.
18.10.1 Key Facts
18.10.2 Financial Overview
18.10.3 Product Benchmarking
18.10.4 Recent Developments
18.10.5 Winning Imperatives
18.10.6 Current Focus & Strategies
18.10.7 Threat from competition
18.10.8 SWOT Analysis

List of Tables

TABLE 1 Global Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 2 Global Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 3 Global Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 4 Global Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 5 Global Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 6 Global Drug Discovery Services Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 7 North America Drug Discovery Services Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 8 North America Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 9 North America Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 10 North America Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 11 North America Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 12 North America Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 13 US Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 14 US Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 15 US Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 16 US Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 17 US Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 18 Canada Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 19 Canada Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 20 Canada Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 21 Canada Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 22 Canada Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 23 Mexico Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 24 Mexico Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 25 Mexico Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 26 Mexico Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 27 Mexico Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 28 Europe Drug Discovery Services Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 29 Europe Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 30 Europe Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 31 Europe Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 32 Europe Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 33 Europe Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 34 Germany Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 35 Germany Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 36 Germany Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 37 Germany Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 38 Germany Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 39 France Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 40 France Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 41 France Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 42 France Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 43 France Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 44 U.K. Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 45 U.K. Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 46 U.K. Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 47 U.K. Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 48 U.K. Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 49 Spain Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 50 Spain Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 51 Spain Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 52 Spain Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 53 Spain Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 54 Italy Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 55 Italy Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 56 Italy Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 57 Italy Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 58 Italy Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 59 Russia Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 60 Russia Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 61 Russia Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 62 Russia Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 63 Russia Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 64 Rest of Europe Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 65 Rest of Europe Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 66 Rest of Europe Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 67 Rest of Europe Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 68 Rest of Europe Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 69 Asia-Pacific Drug Discovery Services Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 70 Asia-Pacific Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 71 Asia-Pacific Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 72 Asia-Pacific Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 73 Asia-Pacific Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 74 Asia-Pacific Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 75 China Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 76 China Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 77 China Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 78 China Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 79 China Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 80 Japan Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 81 Japan Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 82 Japan Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 83 Japan Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 84 Japan Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 85 India Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 86 India Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 87 India Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 88 India Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 89 India Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 90 South Korea Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 91 South Korea Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 92 South Korea Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 93 South Korea Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 94 South Korea Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 95 Rest of Asia-Pacific Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 96 Rest of Asia-Pacific Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 97 Rest of Asia-Pacific Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 98 Rest of Asia-Pacific Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 99 Rest of Asia-Pacific Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 100 Middle East and Africa Drug Discovery Services Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 101 Middle East and Africa Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 102 Middle East and Africa Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 103 Middle East and Africa Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 104 Middle East and Africa Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 105 Middle East and Africa Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 106 GCC Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 107 GCC Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 108 GCC Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 109 GCC Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 110 GCC Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 111 North Africa Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 112 North Africa Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 113 North Africa Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 114 North Africa Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 115 North Africa Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 116 South Africa Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 117 South Africa Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 118 South Africa Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 119 South Africa Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 120 South Africa Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 121 Rest of Middle East & Africa Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 122 Rest of Middle East & Africa Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 123 Rest of Middle East & Africa Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 124 Rest of Middle East & Africa Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 125 Rest of Middle East & Africa Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 126 Latin America Drug Discovery Services Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 127 Latin America Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 128 Latin America Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 129 Latin America Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 130 Latin America Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 131 Latin America Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 132 Brazil Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 133 Brazil Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 134 Brazil Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 135 Brazil Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 136 Brazil Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 137 Argentina Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 138 Argentina Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 139 Argentina Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 140 Argentina Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 141 Argentina Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 142 Rest of Latin America Drug Discovery Services Market Revenue, By Therapeutic Area, 2021 – 2031 (USD Billion)
TABLE 143 Rest of Latin America Drug Discovery Services Market Revenue, By Process, 2021 – 2031 (USD Billion)
TABLE 144 Rest of Latin America Drug Discovery Services Market Revenue, By End-User, 2021 – 2031 (USD Billion)
TABLE 145 Rest of Latin America Drug Discovery Services Market Revenue, By Type, 2021 – 2031 (USD Billion)
TABLE 146 Rest of Latin America Drug Discovery Services Market Revenue, By Drug Type, 2021 – 2031 (USD Billion)
TABLE 147 Company Market Ranking
TABLE 148 Regional Footprint
TABLE 149 Product Benchmarking
TABLE 150 Recent Developments
TABLE 151 Winning Imperatives 

List of Figures

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Drug Discovery Services Market 2021-2031 (USD Billion)
FIG. 4 Global Drug Discovery Services Market Geographical Analysis (CAGR %)
FIG. 5 Global Drug Discovery Services Absolute Market Opportunity (USD Billion)
FIG. 6 Global Drug Discovery Services Market Attractiveness (USD Billion)
FIG. 7 Global Drug Discovery Services Market, By Therapeutic Area, 2021-2031 (USD Billion)
FIG. 8 Global Drug Discovery Services Market, By Process, 2021-2031 (USD Billion)
FIG. 9 Global Drug Discovery Services Market, By End-User, 2021-2031 (USD Billion)
FIG. 10 Global Drug Discovery Services Market, By Type, 2021-2031 (USD Billion)
FIG. 11 Global Drug Discovery Services Market, By Drug Type, 2021-2031 (USD Billion)
FIG. 12 Research Methodology
FIG. 13 Research Process
FIG. 14 Bottom-Up Approach
FIG. 15 Top-Bottom Approach
FIG. 16 Market Dynamics Overview
FIG. 17 Porter's Five Forces Analysis
FIG. 18 Value Chain Analysis
FIG. 19 Macroeconomic Analysis
FIG. 20 Global Drug Discovery Services Market Revenue Share, By Therapeutic Area, 2023 and 2031 (%)
FIG. 21 Global Drug Discovery Services Market Revenue Share, By Process, 2023 and 2031 (%)
FIG. 22 Global Drug Discovery Services Market Revenue Share, By End-User, 2023 and 2031 (%)
FIG. 23 Global Drug Discovery Services Market Revenue Share, By Type, 2023 and 2031 (%)
FIG. 24 Global Drug Discovery Services Market Revenue Share, By Drug Type, 2023 and 2031 (%)
FIG. 25 Global Drug Discovery Services Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 27 North America Drug Discovery Services Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 29 Europe Drug Discovery Services Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 31 Asia-Pacific Drug Discovery Services Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 33 Middle East & Africa Drug Discovery Services Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 34 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 35 Latin America Drug Discovery Services Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 36 Key Strategic Development
FIG. 37 Key Facts
FIG. 38 Financial Overview
FIG. 39 SWOT Analysis